LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 2 | B16 | 72 | hr | 765 | 780 | 3151 | 0.2475 | 0.0095 |
Hs 578T | Tozasertib | 0.37 | uM | LJP5 | 3 | B16 | 72 | hr | 765 | 762 | 3152 | 0.2417 | -0.0020 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 1 | B15 | 72 | hr | 765 | 696 | 3140 | 0.2216 | -0.0454 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 2 | B15 | 72 | hr | 765 | 730 | 3151 | 0.2316 | -0.0227 |
Hs 578T | Tozasertib | 1.11 | uM | LJP5 | 3 | B15 | 72 | hr | 765 | 830 | 3152 | 0.2633 | 0.0407 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 1 | B14 | 72 | hr | 765 | 804 | 3140 | 0.2560 | 0.0247 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 2 | B14 | 72 | hr | 765 | 756 | 3151 | 0.2399 | -0.0058 |
Hs 578T | Tozasertib | 3.33 | uM | LJP5 | 3 | B14 | 72 | hr | 765 | 751 | 3152 | 0.2382 | -0.0090 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 1 | B13 | 72 | hr | 765 | 700 | 3140 | 0.2229 | -0.0427 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 2 | B13 | 72 | hr | 765 | 755 | 3151 | 0.2396 | -0.0065 |
Hs 578T | Tozasertib | 10 | uM | LJP5 | 3 | B13 | 72 | hr | 765 | 679 | 3152 | 0.2154 | -0.0567 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 1 | N18 | 72 | hr | 765 | 3013 | 3143 | 0.9584 | 0.9588 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 2 | N18 | 72 | hr | 765 | 3019 | 3095 | 0.9752 | 0.9753 |
Hs 578T | Imatinib | 0.04 | uM | LJP6 | 3 | N18 | 72 | hr | 765 | 3056 | 3066 | 0.9967 | 0.9967 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 1 | N17 | 72 | hr | 765 | 3133 | 3143 | 0.9966 | 0.9966 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 2 | N17 | 72 | hr | 765 | 3233 | 3095 | 1.0444 | 1.0435 |
Hs 578T | Imatinib | 0.12 | uM | LJP6 | 3 | N17 | 72 | hr | 765 | 3018 | 3066 | 0.9843 | 0.9843 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 1 | N16 | 72 | hr | 765 | 3273 | 3143 | 1.0411 | 1.0399 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 2 | N16 | 72 | hr | 765 | 3081 | 3095 | 0.9953 | 0.9953 |
Hs 578T | Imatinib | 0.37 | uM | LJP6 | 3 | N16 | 72 | hr | 765 | 3062 | 3066 | 0.9987 | 0.9987 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 1 | N15 | 72 | hr | 765 | 3355 | 3143 | 1.0672 | 1.0648 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 2 | N15 | 72 | hr | 765 | 3186 | 3095 | 1.0292 | 1.0287 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 765 | 3284 | 3066 | 1.0711 | 1.0698 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 1 | N14 | 72 | hr | 765 | 3292 | 3143 | 1.0471 | 1.0457 |
Hs 578T | Imatinib | 3.33 | uM | LJP6 | 2 | N14 | 72 | hr | 765 | 3154 | 3095 | 1.0189 | 1.0186 |